SEC Form 3 · accession 0001013606-18-000055
ENDOLOGIX INC /DE/ · ELGX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeremy B. Hayden
Officer — General Counsel
Period of report
Apr 12, 2018
Accepted (ET)
Apr 23, 2018 · 5:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001013606
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | holding | — | — | — | 47,506 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to PurchaseF2 | $4.21 | holding | — | — | — | Aug 21, 2018 | Aug 21, 2027 | Common Stock | 236,027 | — | D |
Explanation of responses
- F1Performance restricted stock unit award.
- F2Twenty-five percent of the options shall vest upon one year of service and the remaining balance will vest in 36 equal monthly installments thereafter.